Rossari Biotech Limited (BOM:543213)
India · Delayed Price · Currency is INR 502.00
-7.15 (-1.40%)
At close: Aug 21, 2026
Rossari Biotech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 753.07 | 442.02 | 251.7 | 691.98 | 374.77 |
Short-Term Investments | - | 44.01 | 44.38 | 80.62 | 550.64 | 149.64 |
Trading Asset Securities | - | 351 | 573.13 | 375.83 | 259.95 | 119.85 |
Cash & Short-Term Investments | 1,148 | 1,148 | 1,060 | 708.15 | 1,503 | 644.26 |
Cash Growth | -2.17% | 8.36% | 49.62% | -52.87% | 133.22% | -27.08% |
Accounts Receivable | - | 5,574 | 4,745 | 4,251 | 3,537 | 3,049 |
Other Receivables | - | 1.48 | 2.82 | 1.54 | 5.41 | 1.16 |
Receivables | - | 5,587 | 4,760 | 4,260 | 3,545 | 3,064 |
Inventory | - | 4,045 | 3,551 | 2,823 | 1,885 | 1,899 |
Prepaid Expenses | - | 35.91 | 20.11 | 12.48 | 18.31 | 49.49 |
Other Current Assets | - | 1,542 | 1,029 | 631.99 | 263.62 | 436.26 |
Total Current Assets | - | 12,359 | 10,419 | 8,436 | 7,214 | 6,093 |
Property, Plant & Equipment | - | 7,338 | 4,937 | 3,619 | 3,267 | 3,480 |
Long-Term Investments | - | 278.44 | 267.71 | 253.55 | 251.8 | 245.47 |
Goodwill | - | 1,187 | 1,187 | 1,187 | 1,187 | 898.58 |
Other Intangible Assets | - | 1,052 | 1,261 | 1,442 | 1,559 | 1,706 |
Long-Term Deferred Tax Assets | - | 149.43 | 105.13 | 48.1 | 31.99 | 13.53 |
Other Long-Term Assets | - | 523.53 | 784.41 | 736.46 | 164.48 | 130.46 |
Total Assets | - | 22,888 | 18,962 | 15,722 | 13,676 | 12,567 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 3,235 | 2,863 | 2,191 | 1,810 | 1,862 |
Accrued Expenses | - | 74.36 | 54.21 | 33.37 | 95.2 | 97.33 |
Short-Term Debt | - | 2,837 | 754.52 | 625.28 | 290.12 | - |
Current Portion of Long-Term Debt | - | 299.46 | 124.89 | 99.75 | 99.83 | 84.27 |
Current Portion of Leases | - | 76.98 | 77.18 | 20.59 | - | - |
Current Income Taxes Payable | - | 90 | 122.47 | 101.01 | 84.63 | 71.83 |
Current Unearned Revenue | - | 3.32 | 3.61 | 3.9 | 4.19 | 4.48 |
Other Current Liabilities | - | 1,280 | 1,365 | 1,173 | 1,101 | 827.22 |
Total Current Liabilities | - | 7,896 | 5,366 | 4,247 | 3,485 | 2,947 |
Long-Term Debt | - | 943.26 | 1,000 | 333.24 | 349.33 | - |
Long-Term Leases | - | 202.53 | 223.07 | 109.06 | - | - |
Pension & Post-Retirement Benefits | - | 82.6 | 52.57 | 34.24 | 21.82 | 17.82 |
Long-Term Deferred Tax Liabilities | - | 430.46 | 465.67 | 514.72 | 587.2 | 689.49 |
Other Long-Term Liabilities | - | - | - | 5.6 | 80.56 | 861.63 |
Total Liabilities | - | 9,554 | 7,107 | 5,244 | 4,524 | 4,516 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 110.77 | 110.73 | 110.49 | 110.31 | 110.11 |
Additional Paid-In Capital | - | 4,732 | 4,751 | 4,686 | 4,641 | 4,591 |
Retained Earnings | - | 8,438 | 6,972 | 5,645 | 4,366 | 3,318 |
Comprehensive Income & Other | - | 53.3 | 21.14 | 35.36 | 35.03 | 32.85 |
Shareholders' Equity | 13,333 | 13,333 | 11,854 | 10,477 | 9,152 | 8,052 |
Total Liabilities & Equity | - | 22,888 | 18,962 | 15,722 | 13,676 | 12,567 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 4,359 | 4,359 | 2,180 | 1,188 | 739.28 | 84.27 |
Net Cash (Debt) | -3,211 | -3,211 | -1,120 | -479.77 | 763.29 | 559.99 |
Net Cash Growth | - | - | - | - | 36.30% | -36.62% |
Net Cash Per Share | -57.95 | -57.95 | -20.24 | -8.67 | 13.79 | 10.15 |
Filing Date Shares Outstanding | 55.35 | 55.38 | 55.36 | 55.25 | 55.16 | 55.06 |
Total Common Shares Outstanding | 55.35 | 55.38 | 55.36 | 55.25 | 55.16 | 55.06 |
Working Capital | - | 4,463 | 5,054 | 4,188 | 3,729 | 3,146 |
Book Value Per Share | 240.75 | 240.75 | 214.12 | 189.65 | 165.92 | 146.24 |
Tangible Book Value | 11,094 | 11,094 | 9,406 | 7,849 | 6,405 | 5,447 |
Tangible Book Value Per Share | 200.32 | 200.32 | 169.90 | 142.07 | 116.13 | 98.93 |
Land | - | 101.42 | 101.42 | 101.42 | 101.42 | 101.42 |
Buildings | - | 1,732 | 1,697 | 1,666 | 1,693 | 1,670 |
Machinery | - | 5,075 | 2,904 | 2,379 | 2,114 | 2,056 |
Construction In Progress | - | 1,733 | 1,402 | 472.09 | 130.72 | 13.42 |
Leasehold Improvements | - | 83.37 | 81.02 | - | - | - |